Related Experiment Video
Updated: May 28, 2026

An Integrated Platform for Genome-wide Mapping of Chromatin States Using High-throughput ChIP-sequencing in Tumor Tissues
Published on: April 5, 2018
Somatic mutations in the chromatin remodeling gene ARID1A occur in several tumor types
Siân Jones1, Meng Li, D Williams Parsons
1Ludwig Center for Cancer Genetics and Therapeutics and Howard Hughes Medical Institute, Johns Hopkins Kimmel Cancer Center, Baltimore, Maryland, USA.
Abstract:
Mutations in the chromatin remodeling gene ARID1A have recently been identified in the majority of ovarian clear cell carcinomas (OCCCs). To determine the prevalence of mutations in other tumor types, we evaluated 759 malignant neoplasms including those of the pancreas, breast, colon, stomach, lung, prostate, brain, and blood (leukemias). We identified truncating mutations in 6% of the neoplasms studied; nontruncating somatic mutations were identified in an additional 0.4% of neoplasms. Mutations were most commonly found in gastrointestinal samples with 12 of 119 (10%) colorectal and 10 of 100 (10%) gastric neoplasms, respectively, harboring changes. More than half of the mutated colorectal and gastric cancers displayed microsatellite instability (MSI) and the mutations in these tumors were out-of-frame insertions or deletions at mononucleotide repeats. Mutations were also identified in 2-8% of tumors of the pancreas, breast, brain (medulloblastomas), prostate, and lung, and none of these tumors displayed MSI. These findings suggest that the aberrant chromatin remodeling consequent to ARID1A inactivation contributes to a variety of different types of neoplasms.
Insights
Mutations in the ARID1A gene, a chromatin remodeling gene, are common in ovarian clear cell carcinomas. This study found ARID1A mutations in 6% of various cancers, particularly gastrointestinal tumors, suggesting its role in diverse neoplasm development.
Area of Science:
- Oncology
- Genetics
- Molecular Biology
Background:
- Mutations in the ARID1A gene are frequently observed in ovarian clear cell carcinomas (OCCCs).
- ARID1A plays a crucial role in chromatin remodeling, influencing gene expression and cellular processes.
- Understanding the broader mutational landscape of ARID1A is essential for comprehending its role in tumorigenesis.
Purpose of the Study:
- To investigate the prevalence and spectrum of ARID1A mutations across a wide range of human malignant neoplasms.
- To identify specific tumor types where ARID1A alterations are common.
- To explore potential correlations between ARID1A mutations and clinicopathological features like microsatellite instability (MSI).
Main Methods:
- Genomic DNA analysis of 759 malignant neoplasms from various origins (pancreas, breast, colon, stomach, lung, prostate, brain, blood).
- Sequencing and mutation analysis to detect truncating and nontruncating somatic mutations in the ARID1A gene.
- Assessment of microsatellite instability (MSI) status in tumors harboring ARID1A mutations.
Main Results:
- ARID1A mutations were identified in 6% of the evaluated neoplasms, with an additional 0.4% showing nontruncating somatic mutations.
- Colorectal (10%) and gastric (10%) neoplasms showed the highest frequency of ARID1A mutations.
- Over half of mutated colorectal and gastric cancers exhibited microsatellite instability (MSI), often linked to frameshift mutations at mononucleotide repeats.
Conclusions:
- ARID1A inactivation, leading to aberrant chromatin remodeling, is implicated in the development of a diverse array of cancers beyond OCCCs.
- The high prevalence in gastrointestinal cancers, especially those with MSI, highlights a specific pathway of ARID1A-driven tumorigenesis.
- These findings underscore the importance of ARID1A as a potential therapeutic target across multiple cancer types.
Related Concept Videos
Cancers Originate from Somatic Mutations in a Single Cell
Cancers Originate from Somatic Mutations in a Single Cell
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
Nucleosome Remodeling
Nucleosome remodeling complex
Eukaryotic cells have specialized enzymes called ATP-dependent nucleosome remodeling enzymes. These enzymes...
Abnormal Proliferation

